Harvard Bioscience, Inc. is a pharmaceutical company based in the United States with an ESG score of 22.9, indicating a medium risk. The company develops and sells specialized products and services for fundamental research and pre-clinical testing in drug development. Its focus is on scientific instruments for advancing life sciences and research. With operations in North America, Europe, and China, Harvard Bioscience sells its products worldwide through direct and distribution channels. The company's product brands include Harvard Apparatus, DSI, Buxco, and others. Majority of its revenue comes from the United States.